Bristol Myers Squibb’s examination into whether its heart med Camzyos can spark improvements in patients with non-obstructive hypertrophic cardiomyopathy (nHCM) turned out to be a conclusive ...

Camzyos missed both primary endpoints in the Phase 3 ODYSSEY-HCM trial for nHCM. No new safety concerns were identified in the 48-week clinical study. China’s new tariffs just reignited the same ...

(Reuters) -Bristol Myers Squibb's drug to treat a type of heart disease did not significantly improve functional capacity and ...

The New Jersey-based company's shares fell 1.6% in extended trading. The drug, mavacamten, was tested in adult patients with ...

In patients with nonobstructive hypertrophic cardiomyopathy (nHCM) treatment with a cardiac myosin inhibitor does not seem to yield significant improvements in quality-of-life (QoL) or oxygen ...

Authorities released new body camera video from inside the New Mexico home where legendary actor Gene Hackman and his wife, Betsy Arakawa, were found dead in February. An investigative report also ...

class II-III non-obstructive hypertrophic cardiomyopathy (nHCM) did not meet its dual primary endpoints of changes from baseline to Week 48 compared to placebo in the Kansas City Cardiomyopathy ...

Walker went 0-for-4 with a strikeout Wednesday against the Cardinals. Walker hasn't produced much this season, as he's collected only 10 hits across 65 at-bats with two extra-base knocks.

Chipmaker Nvidia (NVDA) has launched its new GeForce RTX 5060 Desktop graphics cards, which include the GeForce RTX 5060 Ti that will be available from April 16 in both 8GB and 16GB versions. The ...

The Trump administration released documents Wednesday that revealed new details in the case of Kilmar Abrego Garcia, a Maryland man deported to El Salvador a month ago in what a government lawyer ...